000566 海南海药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.771-5.0380.487-53.128-14.210
总资产报酬率 ROA (%)-0.213-1.4460.134-16.687-5.511
投入资产回报率 ROIC (%)-0.269-1.7800.169-20.173-6.472

边际利润分析
销售毛利率 (%)38.96438.55943.18240.35943.712
营业利润率 (%)-5.484-8.160-3.456-75.336-32.242
息税前利润/营业总收入 (%)3.2842.5046.091-65.951-24.922
净利润/营业总收入 (%)-6.735-9.1540.133-77.590-29.749

收益指标分析
经营活动净收益/利润总额(%)93.307166.518323.76230.24793.250
价值变动净收益/利润总额(%)-7.759-14.974-334.87010.420-20.069
营业外收支净额/利润总额(%)3.719-1.751-4.3950.3060.385

偿债能力分析
流动比率 (X)0.6850.6700.6310.7511.039
速动比率 (X)0.5930.5840.5620.6960.979
资产负债率 (%)70.89270.13068.26971.48361.363
带息债务/全部投入资本 (%)53.37256.57457.62857.269--
股东权益/带息债务 (%)66.24460.82862.88358.02577.455
股东权益/负债合计 (%)38.61939.92243.05135.95358.756
利息保障倍数 (X)0.3660.2380.648-6.858-3.348

营运能力分析
应收账款周转天数 (天)99.63283.75081.892104.0390.000
存货周转天数 (天)136.606118.47695.65382.2300.000